Ticker Details
Candel Therapeutics, Inc. Common Stock
IPO Date:	July 27, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$723.18M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.25 | 5.22%
Avg Daily Range (30 D):	$0.34 | 3.75%
Avg Daily Range (90 D):	$0.25 | 3.44%

Institutional Daily Volume
Avg Daily Volume:	.86M
Avg Daily Volume (30 D):	1.66M
Avg Daily Volume (90 D):	1.66M

Trade Size
Avg Trade Size (Sh.):	150
Avg Trade Size (Sh.) (30 D):	87
Avg Trade Size (Sh.) (90 D):	105

Institutional Trades
Total Institutional Trades:	188
Avg Institutional Trade:	$1.55M
Avg Institutional Trade (30 D):	$2.55M
Avg Institutional Trade (90 D):	$1.75M
Avg Institutional Trade Volume:	.2M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.92M
Avg Closing Trade (30 D):	$2.63M
Avg Closing Trade (90 D):	$1.85M
Avg Closing Volume:	244.06K

News

Feb 20, 2026 @ 1:56 PM Stock Market Today: Dow Jones, S&P 500 Futures Sl... Source: Rishabh Mishra

Feb 20, 2026 @ 2:40 AM Candel Therapeutics Announces Pricing of Public Of... Source: Na

Feb 19, 2026 @ 9:05 PM Candel Therapeutics Announces Proposed $100 Millio... Source: Globe Newswire

Jan 23, 2026 @ 10:52 AM Oncolytic Virotherapy Market - Global Industry Siz... Source: Researchandmarkets.Com

Nov 4, 2025 @ 2:00 PM Candel Therapeutics Showcases Immunotherapy Leader... Source: Candel Therapeutics

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.99	$-.14	$-.55
Diluted EPS	$-.99	$-.14	$-.55
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-54.42M	$-8.86M	$-29.5M
Operating Income / Loss	$-56.42M	$-16.28M	$-15.75M
Cost of Revenue
Net Cash Flow	$102.82M	$75.1M	$32.92M
PE Ratio